Walter Hermann Hörl

Walter Hermann Hörl's AcademicInfluence.com Rankings

Walter Hermann Hörl

Philosophy

#4960

World Rank

#7649

Historical Rank

Logic

#2313

World Rank

#3281

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Walter Hermann Hörl's Degrees

PhD Medicine University of Vienna
Doctorate Medicine University of Vienna

Why Is Walter Hermann Hörl Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walter Hermann Hörl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. (2004) (873)
The TSC-mTOR signaling pathway regulates the innate inflammatory response. (2008) (718)
Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 production (2000) (388)
Effect of age on human neutrophil function (2000) (376)
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. (2013) (348)
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. (2002) (308)
Nutritional status in dialysis patients: a European consensus. (2002) (244)
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. (2001) (232)
A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation (2010) (228)
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. (2002) (227)
Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. (2005) (227)
Hemodialysis-associated hypertension: pathophysiology and therapy. (2002) (218)
Everolimus in patients with autosomal dominant polycystic kidney disease. (2010) (208)
Molecular biology of 5,10-methylenetetrahydrofolate reductase. (2000) (201)
Immune dysfunction in uremia. (1997) (198)
Nonsteroidal Anti-Inflammatory Drugs and the Kidney (2010) (197)
ESPEN Guidelines on Enteral Nutrition: Adult renal failure. (2006) (195)
Serum amyloid A in uremic HDL promotes inflammation. (2012) (189)
Early basal insulin therapy decreases new-onset diabetes after renal transplantation. (2012) (186)
The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity (2009) (182)
Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. (1998) (178)
Importance of iron supply for erythropoietin therapy. (1995) (164)
C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. (2001) (141)
Clinical aspects of iron use in the anemia of kidney disease. (2007) (141)
Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2012) (141)
Anemia and iron deficiencies among long-term renal transplant recipients. (2002) (137)
Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. (2002) (136)
Immune Dysfunction in Uremia—An Update (2012) (133)
Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. (1997) (132)
PRE-dialysis survey on anaemia management. (2003) (128)
Plasma levels of main granulocyte components during cardiopulmonary bypass. (1988) (128)
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. (2000) (127)
Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. (2012) (126)
Current concepts of molecular defence mechanisms operative during urinary tract infection (2008) (124)
Effect of early correction of anemia on the progression of CKD. (2006) (121)
Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. (2011) (121)
The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. (2004) (118)
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig‐Therasorb) (2001) (117)
Anaemia management and mortality risk in chronic kidney disease (2013) (117)
Significance of Interdialytic Weight Gain versus Chronic Volume Overload: Consensus Opinion (2013) (115)
Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy (2004) (114)
Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. (2005) (112)
Patient and graft survival in older kidney transplant recipients: does age matter? (2004) (108)
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments. (1999) (105)
Common errors in diagnosis and management of urinary tract infection. I: pathophysiology and diagnostic techniques. (1999) (105)
Iron overload and cardiovascular complications in dialysis patients. (2002) (100)
Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. (1996) (100)
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. (2012) (99)
Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. (1988) (97)
Recent insights into the molecular genetics of the homocysteine metabolism. (2001) (95)
Glucose Metabolism After Renal Transplantation (2013) (94)
Anemia and carnitine supplementation in hemodialyzed patients. (1999) (94)
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. (2013) (94)
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status (2013) (93)
Tamm‐Horsfall protein: a multilayered defence molecule against urinary tract infection (2005) (92)
Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formation. (2005) (91)
Dysfunction of polymorphonuclear leukocytes in uremia. (1996) (91)
Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. (1991) (90)
Uremia and infection: mechanisms of impaired cellular host defense. (1993) (90)
Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. (1985) (89)
Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. (1990) (89)
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. (2003) (88)
Urinary tract infection in renal transplant recipients (2008) (88)
The versatility of HDL: a crucial anti‐inflammatory regulator (2010) (88)
Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. (2001) (87)
Pure red cell aplasia induced by erythropoiesis-stimulating agents. (2008) (87)
Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients—Incidences and Impact on Long‐Term Allograft Outcomes (2008) (86)
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. (2012) (84)
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. (1998) (82)
Release of granulocyte proteinases during hemodialysis. (1983) (82)
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia. (2007) (80)
Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes (2008) (79)
Quality of water used for haemodialysis: bacteriological and chemical parameters. (1999) (79)
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? (2004) (79)
Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis. (1985) (79)
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study (2009) (79)
Antioxidants: A Possible Role in Kidney Protection (2003) (78)
How to diagnose and correct iron deficiency during r-huEPO therapy--a consensus report. (1996) (77)
Pivotal Role of Complement‐Fixing HLA Alloantibodies in Presensitized Kidney Allograft Recipients (2006) (76)
Vitamin C in Chronic Kidney Disease and Hemodialysis Patients (2003) (76)
New insights into the regulation of iron homeostasis (2006) (76)
Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment. (1994) (74)
CMV Late Phase‐Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages (2012) (73)
Erythropoietin and iron. (1997) (73)
Sexual hormone abnormalities in male patients with renal failure. (2002) (73)
Hepcidin: a molecular link between inflammation and anaemia. (2004) (72)
Donor heme oxygenase-1 genotype is associated with renal allograft function1 (2004) (72)
Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. (1999) (71)
Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease (2012) (71)
Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. (1995) (71)
Practical guidelines for the use of NESP in treating renal anaemia. (2001) (70)
Pathobiology of the role of iron in infection. (1999) (70)
Risk Factors for Capillary C4d Deposition in Kidney Allografts: Evaluation of a Large Study Cohort (2004) (70)
C‐Reactive Protein and Body Mass Index Independently Predict Mortality in Kidney Transplant Recipients (2004) (69)
Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. (1994) (69)
Treatment of renal anemia with recombinant human erythropoietin. (1989) (68)
Iron and infection. (1999) (68)
Elimination of Acquired Factor VIII Antibodies by Extracorporal Antibody-based Immunoadsorption (Ig-Therasorb®) (1995) (68)
Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. (2004) (67)
In Vitro Detection of C4d‐Fixing HLA Alloantibodies: Associations With Capillary C4d Deposition in Kidney Allografts (2007) (66)
Inorganic phosphate and FGF‐23 predict outcome in stable systolic heart failure (2012) (66)
[Aminoglycoside-induced nephrotoxicity]. (1997) (66)
IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study (2005) (65)
Is there a role for adjuvant therapy in patients being treated with epoetin? (1999) (64)
Pharmacokinetics of Meropenem in Patients with Renal Failure and Patients Receiving Renal Replacement Therapy (2000) (63)
Anaemia as a risk factor for the progression of chronic kidney disease (2003) (63)
Safety of intravenous injection of iron saccharate in haemodialysis patients. (1996) (63)
Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study. (2006) (62)
Immunoadsorption in Goodpasture's syndrome. (2000) (61)
Fat-Soluble Vitamins in Patients with Acute Renal Failure (1998) (61)
European best practice guidelines 14-16: inadequate response to epoetin. (2000) (60)
Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. (1986) (60)
Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. (1983) (60)
Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients. (2000) (59)
Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. (2009) (58)
Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. (1997) (58)
Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. (1998) (57)
Proteases II. Potential role in health and disease. Proceedings of the second international conference. May 17-20, 1987, Rothenburg, Federal Republic of Germany. (2012) (57)
Urinary tract infections after renal transplantation (2002) (56)
New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients. (1998) (56)
Enhanced proteolytic activity--cause of protein catabolism in acute renal failure. (1980) (55)
European best practice guidelines 9-13: anaemia management. (2000) (54)
Bacterial metabolite interference with maturation of human monocyte‐derived dendritic cells (2002) (53)
Sodium Setpoint and Sodium Gradient: Influence on Plasma Sodium Change and Weight Gain (2010) (53)
Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. (2000) (53)
New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. (1998) (53)
Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. (2000) (52)
Neutrophil function and infections in uremia. (1999) (52)
Effect of erythropoietin on cardiovascular diseases. (2001) (51)
Peri-operative immunoadsorption in sensitized renal transplant recipients. (2002) (51)
Atherosclerosis and uremic retention solutes. (2004) (50)
Prevention of CD40‐Triggered Dendritic Cell Maturation and Induction of T‐Cell Hyporeactivity by Targeting of Janus Kinase 3 (2003) (50)
Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia. (2000) (50)
Statin use is associated with prolonged survival of renal transplant recipients. (2008) (50)
Determinants of the Complement-Fixing Ability of Recipient Presensitization Against HLA Antigens (2007) (50)
Pre-transplant predictors of cerebrovascular events after kidney transplantation. (2007) (50)
Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation. (1987) (49)
Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. (1986) (49)
Iron therapy for renal anemia: how much needed, how much harmful? (2007) (49)
Impairment of transendothelial leukocyte migration by iron complexes. (2003) (48)
Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. (2001) (48)
Differential effects of growth hormone therapy in malnourished hemodialysis patients. (2001) (47)
Simplified citrate anticoagulation for high-flux hemodialysis. (2001) (47)
Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients. (2002) (46)
Cinacalcet Increases Calcium Excretion in Hypercalcemic Hyperparathyroidism After Kidney Transplantation (2008) (46)
Manidipine regulates the transcription of cytokine genes. (1992) (46)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. (2000) (45)
Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies. (1992) (45)
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease. (2012) (45)
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function (2005) (44)
Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease. (2004) (44)
Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. (2001) (44)
Percentage of Hypochromic Red Blood Cells is an Independent Risk Factor for Mortality in Kidney Transplant Recipients (2004) (44)
Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis (2003) (43)
Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? (2001) (43)
Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. (2001) (42)
Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. (2002) (42)
Cardiac depressant factors in renal disease. (1993) (42)
European best practice guidelines 1-4: evaluating anaemia and initiating treatment. (2000) (42)
Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? (1996) (42)
Contribution of anaemia to progression of renal disease: a debate. (2002) (41)
Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. (2004) (41)
Predialysis Survey on Anemia Management: patient referral. (2003) (41)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. (2001) (40)
Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients. (1995) (40)
OPTA—malnutrition in chronic renal failure (2007) (40)
The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: A European perspective. (2006) (39)
Influence of plasma immunoglobulin level on antibody synthesis. (2002) (39)
Isolation of a granulocyte inhibitory protein from uraemic patients with homology of beta 2-microglobulin. (1994) (39)
Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial. (2006) (39)
Safety Aspects of Parenteral Iron in Patients with End-Stage Renal Disease (1997) (39)
Common errors in diagnosis and management of urinary tract infection. II: clinical management. (1999) (39)
A critical appraisal for definition of hyperfiltration. (2004) (39)
Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. (2000) (39)
Solid phase detection of C4d‐fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients (2013) (39)
Evidence for the participation of granulocyte proteinases on intradialytic catabolism. (1984) (38)
Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uremic patients. (1998) (38)
Effect of malnutrition and uremia on impaired cellular host defence. (1992) (38)
Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study) (2013) (38)
Protocol biopsies after kidney transplantation (2005) (37)
The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. (2004) (37)
European best practice guidelines 6-8: assessing and optimizing iron stores. (2000) (37)
Natriuretic Peptides in Chronic Kidney Disease and During Renal Replacement Therapy (2009) (36)
Natriuretic Peptides in Acute and Chronic Kidney Disease and during Renal Replacement Therapy (2005) (36)
Increased total cytokeratin-18 serum and urine levels in chronic kidney disease. (2011) (36)
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? (1998) (36)
High prevalence of hyperhomocysteinemia in critically ill patients (2000) (36)
Tidal peritoneal dialysis for home-treated patients: should it be preferred? (1999) (35)
Immunoadsorption and Plasma Exchange in Pregnancy (2002) (35)
Bacterial infections after renal transplantation. (1997) (35)
Differentiating Factors Between Erythropoiesis-Stimulating Agents (2004) (35)
Iron metabolism and iron substitution during erythropoietin therapy. (1994) (35)
Effects of Tamm-Horsfall protein on polymorphonuclear leukocyte function. (2004) (34)
PROGRESS IN UREMIC TOXIN RESEARCH: Resistin as a Cardiovascular and Atherosclerotic Risk Factor and Uremic Toxin (2009) (34)
European best practice guidelines 5: target haemoglobin. (2000) (34)
Erythropoietin-inducible immediate-early genes in human vascular endothelial cells. (2000) (34)
Anaemia and the heart (2005) (34)
Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl. (2012) (34)
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption (2003) (34)
Non-erythropoietin-based anaemia management in chronic kidney disease. (2002) (33)
The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes. (2013) (33)
Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin. (2005) (33)
Glucose Control is Associated With Patient Survival in Diabetic Patients After Renal Transplantation (2010) (32)
Endothelial Progenitor Cells in Kidney Transplant Recipients (2006) (32)
Kidney biopsy in patients with diabetes mellitus. (2011) (32)
VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome (2009) (32)
Quantification of leukocyte migration: improvement of a method. (1996) (32)
Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients? (1996) (32)
Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America (2011) (32)
Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous. (1992) (31)
Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation. (2007) (31)
Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients. (2005) (31)
Inhibition of degranulation of human polymorphonuclear leukocytes by complement factor D (1995) (31)
Healthcare systems. An international review. Introduction. (1999) (31)
Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a combined analysis of eight multicenter trials. (2007) (30)
Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions (2004) (30)
Living on chronic hemodialysis between dryness and fluid overload. (1997) (30)
Potential risk for infection and atherosclerosis due to iron therapy. (2005) (30)
How to get the best out of r-HuEPO. (1995) (30)
Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients. (2001) (30)
PROGRESS IN UREMIC TOXIN RESEARCH: Free Immunoglobulin Light Chains as a Risk Factor in Renal and Extrarenal Complications (2009) (30)
Broadband Ultrasound Attenuation of the Calcaneus (1998) (30)
Recombinant human granulocyte colony-stimulating factor after kidney transplantation: a retrospective analysis to evaluate the benefit or risk of immunostimulation. (2000) (30)
Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes (2000) (30)
Dialysate sodium prescription and blood pressure in hemodialysis patients. (2014) (30)
Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. (2001) (30)
The Next Step from High-Flux Dialysis: Application of Sorbent Technology (2002) (30)
High dose intravenous iron: a note of caution. (2002) (30)
Hormonal adjuvants for the treatment of renal anaemia (2005) (29)
The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients. (2008) (29)
p38α Senses Environmental Stress To Control Innate Immune Responses via Mechanistic Target of Rapamycin (2013) (29)
Ferrous sulfate does not affect mycophenolic acid pharmacokinetics in kidney transplant patients. (2004) (29)
PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research (2009) (28)
HYPERTENSION IN HEMODIALYSIS PATIENTS: Drug Therapy for Hypertension in Hemodialysis Patients (2004) (28)
Plasma levels of main granulocyte components during hemodialysis. (1987) (28)
Angiotensin converting enzyme DD genotype is associated with hypertensive crisis* (2002) (28)
Ultrasonography of the catheter tunnel in peritoneal dialysis patients: what are the indications? (1999) (28)
N-TERMINAL FRAGMENTS OF THE PROATRIAL NATRIURETIC PEPTIDE IN PLASMA AND URINE OF KIDNEY GRAFT RECIPIENTS (2001) (27)
Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients. (1990) (27)
Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients. (2006) (27)
Membranous glomerulonephritis (MGN) (2000) (27)
Anaphylactoid reactions during hemodialysis. (1994) (27)
Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity. (2009) (27)
Neutrophil activation in acute renal failure and sepsis. (1990) (27)
Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan. (1987) (26)
Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. (2014) (26)
Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate. (1994) (26)
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. (2005) (26)
Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes. (1993) (26)
Granulocyte activation during hemodialysis. (1986) (26)
Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients. (1999) (26)
Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. (2005) (26)
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects. (1991) (26)
Impaired cellular host defence in peritoneal dialysis by two granulocyte inhibitory proteins. (1994) (25)
Intravenous iron therapy: well‐tolerated, yet not harmless (2005) (25)
C4d deposits in renal allografts are associated with inferior graft outcome. (2001) (25)
High incidence of nephrogenic adenoma of the bladder after renal transplantation. (1998) (25)
Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis. (2002) (24)
The immune system in uremia and during its treatment. (1995) (24)
Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension (2006) (24)
Localization and characterization of the novel protein encoded by C20orf3. (2008) (24)
Clinical significance of granulocyte-inhibiting proteins. (2000) (24)
Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression (1995) (24)
Role of proteases in hypercatabolic patients with renal failure. (1983) (23)
G-Protein &bgr;3 subunit gene (GNB3) polymorphism 825C→T in patients with hypertensive crisis (2000) (23)
Inhibition of Human Dendritic Cell Maturation and Function by the Novel Immunosuppressant FK778 (2005) (23)
GIP and DIP: a new view of uraemic toxicity. (1994) (23)
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity (2010) (23)
Cardiovascular effects of increasing hemoglobin in chronic renal failure. (1996) (23)
Protein catabolism in acute renal failure. (1997) (23)
Serum Proteins Modified by Neutrophil-Derived Oxidants as Mediators of Neutrophil Stimulation1 (2001) (23)
Refractory Wegener’s granulomatosis responds to tumor necrosis factor blockade (2004) (23)
The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures. (1997) (22)
Carnitine and carnitine esters in acute renal failure. (1989) (22)
Late onset Pneumocystis pneumonia in renal transplantation after long‐term immunosuppression with belatacept (2009) (22)
A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8. (1994) (22)
Reversibility of ‘Secondary Hypercalcitoninemia’ After Kidney Transplantation (2005) (22)
Angiogenic factors in plasma of brain tumour patients. (2009) (22)
Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients. (2012) (22)
The role of tidal peritoneal dialysis in modern practice: A European perspective. (2006) (22)
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. (1996) (22)
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial (2012) (22)
Modified solid-phase alloantibody detection for improved crossmatch prediction. (2013) (22)
Metabolic response of neutrophils to uremia and dialysis. (1989) (22)
Multifactorial Determination of Hypertensive Nephroangiosclerosis (2003) (22)
Novel aspects of erythropoietin response in renal failure patients. (2001) (22)
Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis. (1989) (22)
Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes. (1987) (22)
Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. (1997) (21)
In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure. (1982) (21)
Magic mushrooms: hope for a 'cheap high' resulting in end-stage renal failure. (1996) (21)
Hyporesponsiveness in Alloreactive T‐cells by NF‐κB Inhibitor‐Treated Dendritic Cells: Resistance to Calcineurin Inhibition (2004) (21)
Adjunctive therapy in anaemia management. (2002) (20)
Hypertension and Dialysis (2003) (20)
History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. (2005) (20)
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. (2006) (20)
Release of Leukocyte Elastase during Hemodialysis (1985) (20)
Impairment of T cell interactions with antigen‐presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF‐κB in immunological synapse formation (2007) (20)
Iron status of dialysis patients under rhuEPO therapy. (1990) (20)
Proteases: potential role in health and disease. (1984) (19)
Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients. (2001) (19)
Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patients (1996) (19)
A need for an individualized approach to end-stage renal disease patients. (2002) (19)
Release of leukocyte elastase during hemodialysis. Effect of different dialysis membranes. (1985) (19)
A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results. (2001) (19)
Angiogenin: A Novel Inhibitor of Neutrophil Lactoferrin Release during Extracorporeal Circulation (2003) (19)
Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia. (2000) (18)
Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation. (2003) (18)
Effect of dialyzer geometry on granulocyte and complement activation. (1987) (18)
Release of granulocyte neutral proteinases in patients with acute and chronic renal failure. (1984) (18)
[Treatment of renal anemia with darbepoetin alfa: results of an Austrian multicenter study]. (2002) (18)
Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes. (1999) (18)
Online haemodiafiltration: definition, dose quantification and safety revisited (2013) (18)
Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption. (2000) (18)
Influence of the preceding exchange on peritoneal equilibration test results: a prospective study. (1999) (17)
Uremic pneumonitis. Evidence for participation of proteolytic enzymes. (1984) (17)
Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia? (1996) (17)
The patient with end-stage renal failure and ascites. (1997) (17)
A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation (2010) (17)
Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients (2001) (17)
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy (2006) (17)
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations. (2008) (17)
Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature (2013) (17)
Magic mushrooms: hope for a ‘cheap high’ resulting in end-stage renal failure (1996) (17)
Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia. (2002) (17)
The course of anticardiolipin antibody levels under immunoadsorption therapy. (2005) (16)
Treatment of hypertension in renal transplant recipients (2003) (16)
Smoking as a Risk Factor for Renal Injury in Essential Hypertension (2006) (16)
Should we still use iron dextran in hemodialysis patients? (2001) (16)
Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. (2004) (16)
Can the hypercatabolic state in acute renal failure be modified by treatment (1994) (16)
Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation (2004) (16)
Adult respiratory distress syndrome (ARDS): experimental models with elastase and thrombin infusion in pigs. (1984) (16)
Catabolic factors in renal failure: therapeutic approaches. (1988) (15)
Laboratory diagnosis of anaemia in dialysis patients: use of common laboratory tests (1997) (15)
Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. (1989) (15)
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. (1997) (15)
Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia : where are we now and where do we go from here ? (2004) (15)
Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients. (2011) (15)
Gender and living donor kidney transplantation (2011) (15)
Normalization of enhanced neutrophil cytosolic free calcium of hemodialysis patients by 1,25-dihydroxyvitamin D3 or calcium channel blocker. (1993) (15)
Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients (2002) (15)
Hypertension in end-stage renal disease: different measures and their prognostic significance. (2010) (15)
Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis. (1998) (15)
The LDH ratio as a marker for response to plasma exchange in HUS/TTP of the adult. (2002) (15)
Comparative Look at Intravenous Iron Agents: Pharmacology, Efficacy, and Safety of Iron Dextran, Iron Saccharate, and Ferric Gluconate (1999) (15)
Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers. (1987) (15)
European Survey on Anaemia Management (ESAM) - Patients and methods (2000) (15)
Reduction of urea generation and muscle protein degradation by adrenalectomy in acutely uremic rats. (1988) (14)
Assessment of Neutrophil Function in Patients with Septic Shock: Comparison of Methods (2001) (14)
Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II. (2002) (14)
Influence of mycophenolic acid and tacrolimus on homocysteine metabolism. (2002) (14)
The anti-inflammatory potency of dexamethasone is determined by the route of application in vivo. (2010) (14)
Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis. (2004) (14)
New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis (1989) (14)
Effect of MTHFR 1298 A 3 C and MTHFR 677 C 3 T Genotypes on Total Homocysteine , Folate , and Vitamin B 12 Plasma Concentrations in Kidney Graft Recipients (2000) (14)
Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia. (1991) (14)
Aprotinin and renal function in patients undergoing cardiac surgery. (2000) (14)
Multiple‐dose pharmacokinetics of cefpirome in long‐term hemodialysis with high‐flux membranes (1996) (14)
Serum carnitine levels and carnitine esters of patients after kidney transplantation: role of immunosuppression. (1988) (14)
Role of alcohol in clinical nephrology (1985) (14)
SUPPRESSION OF PRIMARY T-CELL RESPONSES AND INDUCTION OF ALLOANTIGEN-SPECIFIC HYPORESPONSIVENESS IN VITRO BY THE JANUS KINASE INHIBITOR TYRPHOSTIN AG4901 (2000) (13)
Is there a role of cyclosporine A on total homocysteine export from human renal proximal tubular epithelial cells? (2001) (13)
Effect of different dialyzer membranes on plasma levels of granulocyte elastase. (1988) (13)
Is Absorption of High-Dose Oral Iron Sufficient in Peritoneal Dialysis Patients? (2000) (13)
A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course. (2001) (13)
Effect of calcium channel blockers on intracellular calcium accumulation. (1994) (13)
Enhanced glycogen turnover in skeletal muscle of uremic rats--cause of uncontrolled actomyosin ATPase? (1978) (13)
OPTA-therapy with iron and erythropoiesis-stimulating agents in chronic kidney disease (2007) (13)
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. (2002) (13)
Genesis of the uraemic syndrome: role of uraemic toxins. (1998) (12)
Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease. (2005) (12)
Detecting prostate cancer by intracellular macrophage prostate‐specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA (2008) (12)
Prognostic associations between lipid markers and outcomes in kidney transplant recipients. (2006) (12)
Long-Term Patient and Graft Survival in the Eurotransplant Senior Program: A Single-Center Experience (2005) (12)
Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis (2009) (12)
[Uremic patients--late referral, early death]. (2003) (12)
A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection. (2002) (12)
What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Measurement of hypochromic red blood cells is not the first line procedure to identify the patient with iron deficiency. (1998) (12)
Uncovering host defences in the urinary tract: cathelicidin and beyond. (2006) (12)
[ACE inhibitors and the kidney]. (1996) (12)
Reduction of degranulation of polymorphonuclear leukocytes by immunosuppression in patients following cadaveric renal transplantation. (1989) (12)
Parathyroid Hormone Secretion During Citrate Anticoagulated Hemodialysis in Acutely Ill Maintenance Hemodialysis Patients (2004) (12)
Efficacy of a Low-Dose Intravenous Iron Sucrose Regimen in Peritoneal Dialysis Patients (2002) (12)
Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia. (1999) (12)
The key role of sex dependency on kidney citrate metabolism in the rat (1985) (11)
Alterations of polymorphonuclear leukocyte glycogen metabolism and glucose uptake in dialysis patients. (1991) (11)
Uremic toxins: new aspects. (2000) (11)
Improvement of dialyzer compatibility by reduction of membrane surface area. (1986) (11)
Detection of a metalloproteinase in patients with acute and chronic renal failure. (1986) (11)
Rapamycin‐associated post‐transplantation glomerulonephritis and its remission after reintroduction of calcineurin‐inhibitor therapy (2004) (11)
Neutrophil activation during hemodialysis. (1989) (11)
Urinary proteinase activity in patients with multiple traumatic injuries, sepsis, or acute renal failure. (1986) (11)
Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo. (1999) (11)
Increased chemokine excretion in patients suffering from chronic kidney disease. (2014) (11)
Urinary apolipoprotein (a) excretion in patients with proteinuria. (1998) (11)
Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers. (2005) (11)
Proteinases in catabolism and malnutrition. (1987) (11)
Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers. (1998) (11)
Laudatio for Professor Sergio Giovannetti (1999) (10)
Sorbent augmented dialysis systems. (2002) (10)
Anaemia after renal transplantation (2005) (10)
Mechanisms for protein catabolism in acute renal failure. (1994) (10)
Normalization of enhanced hepatic gluconeogenesis by the antiglucocorticoid RU 38486 in acutely uraemic rats (1990) (10)
Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis. (1988) (10)
The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells. (2005) (9)
Complement-dependent acceleration of apoptosis in neutrophils by dialyzer membranes. (2001) (9)
Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure. (1988) (9)
[Atherosclerosis and uremia: signifance of non-traditional risk factors]. (2003) (9)
Calcium antagonists in the treatment of hypertension. (1983) (9)
Effect of hemodialysis on intracellular calcium in human polymorphonuclear neutrophils. (1992) (9)
Renal transplantation in the elderly (2001) (9)
Disturbed latex immunoassays for C-reactive protein and ferritin in a renal transplant patient due to polyclonal IgM hypergammaglobulinaemia. (1997) (9)
Plasma levels of main granulocyte components during hemodialysis: effects of immunosuppression. (1987) (9)
Experimental studies on the adult respiratory distress syndrome: effects of induced DIC; granulocytes and elastase in mini pigs (1985) (9)
Calcineurin Inhibitor-Based Immunosuppressive Therapy, Donor Age, and Long-Term Outcome After Kidney Transplantation (2009) (8)
Rapidly progressive glomerulonephritis and carcinoma of the hypopharynx. (2001) (8)
Glycogen metabolism in muscle in uremia. (1980) (8)
Lipoprotein pattern in end-stage renal disease and following successful renal transplantation. (1997) (8)
Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease (2015) (8)
Carbohydrate metabolism in potassium-depleted rats. (1985) (8)
CHAPTER 80 – Other Blood and Immune Disorders in Chronic Kidney Disease (2010) (8)
Impact of parathyroidectomy on neutrophil cytosolic calcium in chronic kidney disease patients: a prospective parallel group trial (2005) (8)
Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients (2000) (8)
[Thrombocytopathy and blood complications in uremia]. (2006) (8)
Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient. (1996) (8)
Effect of immunosuppressive drugs on the release of metalloproteinases from human polymorphonuclear leukocytes (1991) (7)
Comparing the efficacy of intravenous iron and oral iron in nondialysis patients with chronic kidney disease (2008) (7)
Endocrine and metabolic abnormalities following kidney transplantation (1989) (7)
Neutrophil β2-Microglobulin and lactoferrin content in renal failure patients (2000) (7)
Proteases and other catabolic factors in renal failure. (1987) (7)
Leukocyte proteinases and proteinase inhibitors in the catabolism of acute renal failure. (1987) (7)
Neutrophil function in renal failure. (2001) (7)
Degranulation of polymorphonuclear leukocytes by dialysis membranes--the mystery clears up? (2000) (7)
Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass operation. (1986) (7)
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients. (2014) (7)
Contribution of Proteases to Hypercatabolism in Acute Renal Failure (1984) (7)
Renal osteodystrophy: role of calcimimetics. (2003) (7)
Impact of Continuous Ambulatory Peritoneal Dialysis Solutions and Clearance of Macromolecules on Polymorphonuclear Neutrophils (1994) (7)
One-Year Growth Hormone Therapy Improves Granulocyte Function without Major Effects on Nutritional and Anthropometric Parameters in Malnourished Hemodialysis Patients (2003) (7)
Proteolytic activity in patients with hypercatabolic renal failure. (1984) (7)
Effect of biocompatible membranes on neutrophil function and metabolism. (1994) (7)
Tumor lysis syndrome: risk factors and treatment (2005) (6)
New insights into intestinal iron absorption. (2008) (6)
Surface antigens of human mesangial cells: impact of growth surface or IL-1alpha. (2002) (6)
Glycogen metabolism in phosphorus-depleted rats. (1983) (6)
Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis (2014) (6)
Failure to detect remarkable hypomagnesemia in renal transplant recipients receiving ciclosporin. (1990) (6)
Acute renal failure after ibutilide (1999) (6)
Effect of tourniquet ischaemia on carbohydrate metabolism of dog skeletal muscle. (1985) (6)
Molecular Analysis of the Carboxy Terminus of the Beta and Gamma Subunits of the Epithelial Sodium Channel in Patients with End-Stage Renal Disease (1999) (6)
Beta-2-microglobulin and main granulocyte components in hemodialysis patients. (1989) (6)
[Local thrombolysis of renal artery embolism]. (1985) (6)
Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure (1981) (6)
The biology of hemodialysis (2004) (6)
Dialysis: A step towards making online haemodiafiltration a gold standard (2013) (6)
Effect of cyclosporin A on carbohydrate metabolism in the rat * (1989) (6)
Effect of cyclosporin A on carbohydrate metabolism in the rat (1989) (6)
OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD) (2007) (6)
Effect of gamma radiation versus ethylene oxide sterilization of dialyzers and blood lines on plasma levels of granulocyte elastase in hemodialyzed patients. (1985) (6)
The gluconeogenetic ability of hepatocytes in various types of acute uraemia. (1982) (6)
Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes. (2008) (6)
New Aspects of Human Polymorphonuclear Leukocytes (1991) (6)
Abnormalities of glycogen metabolism in cardiomyopathy of phosphorous depletion. (1980) (6)
Effects of high doses of leucine and ketoleucine on glycogen and protein metabolism in acute uremia. (1980) (6)
Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. (2000) (6)
Secondary hyperparathyroidism: present and future therapeutic implications. (2002) (6)
Abnormalities of carbohydrate metabolism in spontaneously hypertensive rats (1988) (6)
Endocrine and metabolic disorders following kidney transplantation. (1992) (5)
Effective hypolipidaemic therapy with beclobrate in haemodialysis patients: interference with L-carnitine. (1990) (5)
Removal of high-molecular-weight toxins. (1992) (5)
European best practice guidelines 17-18: adverse effects. (2000) (5)
Altered cellular host defence in malnutrition and uremia. (1992) (5)
Postprandial blood glucose level in maintenance hemodialysis patients predicts post-transplant-diabetes-mellitus. (2010) (5)
Carbohydrate metabolism and uraemia — Mechanisms for glycogenolysis and gluconeogenesis (1980) (5)
Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification. (2009) (5)
Potential role of carnitine in patients with renal insufficiency (1986) (5)
Extended Abstracts of Invited Lectures (2000) (5)
Adsorption of natriuretic factors in uremia. (2001) (5)
Hepatorenal syndrome. (2002) (4)
Immunoregulation in Urinary Tract Inflammation—A Role of Tamm-Horsfall Glycoprotein Tamm-Horsfall Glycoprotein Links Innate Immune Cell Activation with Adaptive Immunity via a Toll-Like Receptor-4–Dependent Mechanism. J Clin Invest 115: 468–475, 2005 (2005) (4)
Intravenous Iron: The Iatrogenic Kick to Lose Control over Oxygen? (2002) (4)
Characterization of non-TCA-precipitable 'Lowry protein' in plasma of patients with acute renal failure. (1987) (4)
The shampoo clue: two cases of infection of a ventriculoatrial shunt. (2000) (4)
The clinical potential of novel erythropoiesis stimulating protein (2001) (4)
Effect of hormones on hepatocyte gluconeogenesis in different models of acute uraemia. (1982) (4)
Effect of nifedipine on carbohydrate metabolism in the rat (1987) (4)
Iron therapy in patients with chronic kidney disease: taking the high road? (2009) (4)
Switch from a broad range of erythropoiesis stimulating agents to HX575 (biosimilar epoetin alfa): A 6-month prospective multicenter study (2011) (4)
The Medicinal Use of Urine (1999) (4)
Mutations in the carboxy terminus of the beta and gamma subunits of the epithelial sodium channel are not present in patients with hypertensive crisis. (1998) (4)
Beclobrate: pharmacodynamic properties and therapeutic use in hyperlipidemia (2011) (4)
Gross proteinuria and subacute renal failure after coronary angiography – a case report of cholesterol crystal embolization (2010) (4)
Biological action of rapamycin in renal transplantation. (2008) (4)
The novel immunosuppressant FK778 inhibits formation of the immunologic Synapse. (2005) (4)
Kidney biopsy in patients with glomerulonephritis: is the earlier the better? (2012) (4)
Calcium-dependent neutrophil activation. (1992) (4)
Abstracts 1–142 (2000) (4)
[Protein catabolism and tourniquet shock: the role of proteolytic enzymes]. (1982) (4)
Effect of cyclosporin A, azathioprine, and prednisolone on carbohydrate metabolism of rat hepatocytes * (1990) (4)
Effect of cyclosporin A on carbohydrate metabolism of isolated rat liver cells. (1989) (4)
The long-acting dopamine agonist bromocriptine mesylate as additive immunosuppressive drug after kidney transplantation. (1997) (3)
Localization and characterization of the novel protein encoded by C 20 orf 3 (2008) (3)
[Renaissance of diuretics in the treatment of hypertension]. (1999) (3)
5th Annual Meeting of the International Society of Blood Purification (1987) (3)
Painless subcutaneous erythropoietin (rHuEpo) injection--is it the panacea? (1994) (3)
ACE inhibitors in hemodialysis patients: does survival improve? (2002) (3)
Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males. (2000) (3)
Two novel mutations in the beta subunit of the human epithelial sodium channel. (1999) (3)
Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients (2008) (3)
Effect of aprotinin on metabolic changes in blood following aortofemoral bypass operation. (1985) (3)
EFFECT OF ONLINE HAEMODIAFILTRATION ON ALL-CAUSE MORTALITY AND CARDIOVASCULAR OUTCOMES (2013) (3)
Effect of Calcium Channel Blockers on Granulocyte Activation during Hemodialysis1 (1989) (3)
Dialysis: Normovolemia is a therapeutic target for hypertension (2009) (3)
Anemia and its treatment in peritoneal dialysis patients (2005) (3)
Vitamin C for hyporesponsiveness to EPO: a cure for all? (2003) (3)
Multifactoral analysis of determinators for renal injury in essential hypertension (2006) (3)
A peptide isolated from a patient on continuous ambulatory peritoneal dialysis has homology to ubiquitin and inhibits the chemotactic response of polymorphonuclear leukocytes. (1997) (3)
Role of energy charge and redox state for hepatocyte gluconeogenesis of acutely uremic rats. (1985) (3)
History of Nephrology 3 (1999) (3)
Is it necessary to treat metabolic acidosis in chronic renal insufficiency? (1995) (3)
Impaired Glucose Metabolism Despite Decreased Insulin Resistance After Renal Transplantation (2012) (3)
Molecular and clinical characterisation of homocystinuria in two Austrian families with cystathionine beta-synthase deficiency. (2001) (3)
Methylprednisolone reduces dialysis-induced degranulation of specific granules of polymorphonuclear leukocytes in patients with acute renal failure. (1987) (3)
Pathophysiology of ARF in the ICU (1996) (3)
Haemodynamics and myocardial metabolism of phosphorus depleted dogs: effects of catecholamines and angiotensin II (1982) (3)
Inactivation of urinary kallikrein by alpha1-antitrypsin (1981) (3)
[Calcium antagonists in the therapy of hypertension]. (1983) (2)
Bacterial infections after renal transplantation. (1998) (2)
Lisinopril pharmacokinetics and erythropoietin requirement in haemodialysis patients (2012) (2)
4.P.315 Stimulation of LDL receptor expression by LDL-immuno-apheresis in patients with heterozygous familial hypercholesterolemia (1997) (2)
Kidney Independent Serine Synthesis in the Rat (1985) (2)
Anemia: What can we learn from a secondary analysis of CHOIR? (2010) (2)
Ketone body-induced dissociation between hepatocyte gluconeogenesis and ureagenesis in acutely uremic rats. (1992) (2)
Erythropoietin in the 90s (1990) (2)
Mechanisms of abnormal carbohydrate metabolism in uremia. (1986) (2)
How to induce severe electrolyte disturbances in the elderly? (2002) (2)
Role of urinary alpha1-antitrypsin in padutin® (kallikrein) inactivation (2004) (2)
Effect of calcium channel blockers on granulocyte activation during hemodialysis. (1989) (2)
Effect of phosphate depletion on gluconeogenesis in isolated rat hepatocytes. (1984) (2)
Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients (1986) (2)
A Transient Improvement in Renal Function Occurs after Ischemic Stroke (2012) (2)
A patient with sudden abdominal pain 10 years after successful renal transplantation. (2003) (2)
Calcium antagonists: hypotensive and humoral actions in different forms of hypertension. (1985) (2)
Defective hormonal stimulation of isolated hepatocytes in phosphorous depleted rats. (1982) (2)
Iatrogenic hypercalcaemia, hypokalaemia and metabolic alkalosis in a lady with vena cava thrombosis--beware of overzealous diuretic treatment. (1999) (2)
TGF-β1 impairs homocysteine metabolism in human renal cells: possible implications for transplantation (2002) (2)
Hormonal regulation of muscle protein catabolism in acutely uremic rats: effect of adrenalectomy and parathyroidectomy. (1988) (2)
Expanding our interventional skills: placement of totally implantable injection ports by internists/intensivists. (2001) (2)
Anaemia as a risk factor for chronic kidney disease (2009) (2)
Analysis of liver function in renal transplant recipients undergoing C2‐monitoring for cyclosporine (2008) (2)
Professor Bruno Watschinger (2001) (2)
[Glycogen metabolism in isolated peripheral lymphocytes and thrombocytes in hair cell leukemia (HCL), chronic myelocytic leukemia (CML) and normal controls]. (1978) (2)
P-173: Effect of intravenous folic acid or folinic acid therapy on mean arterial pressure (MAP) and pulse pressure (PP) in hemodialysis patients (2001) (2)
Are new toxins appearing on the horizon? (2001) (2)
Drug therapy for hypertension in hemodialysis patients. (2004) (2)
Blood flow dependent granulocyte activation in membranes with and without complement activation. (1991) (2)
Free Immunoglobulin Light Chains (2012) (2)
Cinacalcet effect on polymorphonuclear leucocytes of kidney transplant patients (2013) (2)
Therapy of hyperhomocysteinemia in end-stage renal disease patients. (2001) (2)
Urinary proteinase activity in patients with acute renal failure after trauma and kidney transplantation. (1988) (1)
No Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin 2 Receptor Blocker Intake with Acute Kidney Injury in Patients Undergoing Kidney Biopsy (2012) (1)
No Associations between Prolactin Concentrations and Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients (2007) (1)
Glycogen synthesis from serine in isolated perfused hindquarters of acutely uraemic rats. (1983) (1)
[Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology]. (2001) (1)
Central retinal vein occlusion after transplantation of the kidney (1989) (1)
Recombinant Tissue Plasminogen Activator is a Useful Alternative to Heparin in Priming Quinton Permacath (2019) (1)
Release of granulocyte proteins during cardiopulmonary bypass: effect of different pharmacological interventions. (1988) (1)
Beclobrate: Pharmacodynamic properties and therapeutic use in hyperlipidemia (2005) (1)
[Heart surgery with extracorporeal circulation in long-term hemodialysis patients]. (2008) (1)
Pathophysiology and Treatment of Hyperhomocysteinemia in End‐Stage Renal Disease Patients (2001) (1)
Minimal-change glomerulonephritis associated with infantile autosomal recessive polycystic kidney disease. (1997) (1)
Effect of serine on gluconeogenic ability of hepatocytes in acute uremia. (1983) (1)
Can hemodialysis technique modify the hypercatabolic state? (1996) (1)
Erythropoietin and renal anemia. (1991) (1)
[Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)]. (1978) (1)
Biocompatibility profile of the polysulfone 400 membrane. (1989) (1)
Subject Index Vol. 26, 2003 (2003) (1)
Long-term effects of nifedipine on plasma levels of 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D in hypertensive hemodialyzed patients (1986) (1)
[Severe hemolysis during immunosuppressive therapy with cyclosporin A following kidney transplantation]. (1985) (1)
Janus kinase‐3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation (2004) (1)
[Value of diuretics in hypertension]. (1996) (1)
The uremic syndrome and pathophysiology of chronic renal failure (2004) (1)
haemodia fi ltration : de fi nition , dose quanti fi cation and safety revisited (2013) (1)
Long-term outcome in diabetic patients on hemodialysis treatment. (1989) (1)
Isolation of Protein-Glycogen Complexes from Rat Skeletal Muscle in Acute Uremia: Role of Serine (1982) (1)
Fernando Valderrábano, MD 1942 - 2001 (2002) (1)
[Contrast induced nephropathy]. (2009) (1)
PATIENTS AND METHODS (1990) (1)
Introduction to the Proceedings of the Ninth International Congress on Renal Nutrition and Metabolism (1999) (1)
Intraplatelet calcium levels in patients with acute renal failure. (2001) (1)
Contents Vol. 25, 2002 (2003) (1)
Acute uremia following dietary potassium depletion. I. Effect on blood parameters related to carbohydrate metabolism. (1986) (1)
Granulocyte lysosomal factors and plasma elastase in uremia: A potential factor of catabolism (1984) (1)
Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients (1992) (1)
Glycerol-induced acute renal failure in the rat: protection by exercise. (1987) (1)
Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis. (1989) (1)
PROGRESS IN UREMIC TOXIN RESEARCH: Conservative Treatment of the Uremic Syndrome (2009) (1)
Research update for articles published in EJCI in 2008 (2010) (1)
Mediators in continuous extracorporeal treatment of multiple organ dysfunction syndrome. (1995) (1)
Neutrophil carbohydrate metabolism in patients with essential hypertension and uremia. (1991) (1)
Renal medicine and renal transplantation. (2002) (1)
A translational view on urinary tract infection (2008) (1)
Contents Vol. 103, 2006 (2006) (0)
Consultant List (2002) (0)
[Urinary tract infections]. (2011) (0)
[Comment on the contribution: "Usefulness of fixed analgesic combinations exemplified by thomapyrin"]. (1997) (0)
Contents, Vol. 5, 1987 (1987) (0)
Contents, Vol. 11, 1991 (1991) (0)
[Low protein diet in the treatment of chronic renal failure: effective, but barely used]. (2008) (0)
Immune Dysfunction in Hemodialysis and Peritoneal Dialysis Patients (2000) (0)
Contents Vol. 25, 1999 (1999) (0)
The Development of Our Understanding of Uremia (2012) (0)
P-495: Association of the angiotensin converting enzyme DD genotype with hypertensive crisis (2001) (0)
Re: Experience with a Large Dose (500 mg) of Intravenous Iron Dextran and Iron Saccharate in Peritoneal Dialysis Patients (2001) (0)
Contents Vol. 26, 2003 (2003) (0)
[Are ACE inhibitors nephroprotective?]. (1996) (0)
[Fat and renal failure--therapeutic aspects]. (1982) (0)
Epidemiology & outcome in CKD 5D (1) (2011) (0)
Long‐term evaluation of proliferative donor antigen‐specific reactivity in cadaveric kidney transplant recipients (2000) (0)
Function and Differentiation Rapamycin in Human Dendritic Cell A Versatile Role of Mammalian Target of (2010) (0)
[20 years kidney transplantation. Experience of a practice]. (1991) (0)
Calcium antagonists in the treatment of hypertension. (1982) (0)
Cyclosporin A toxicity, and more: vascular endothelial growth factor (VEGF) steps forward (2004) (0)
Evidence for protein split products in plasma of patients with acute renal failure. (1988) (0)
[Cardiovascular operations in patients with perioperative reduced kidney function]. (1987) (0)
[Infusions of amino acid solutions in the therapy concept of trauma patients. Comparative studies in the early phase of polytrauma]. (1988) (0)
Author / Subject Indexes (2004) (0)
Subject Index Vol. 25, 1999 (1999) (0)
Dialysis Procedures and Timing in Chronic Renal Failure (2002) (0)
[Nutrition in acute and chronic kidney replacement therapy]. (1999) (0)
Subject Index Vol. 103, 2006 (2006) (0)
[Acute renal failure]. (1992) (0)
Effect of immunosuppression on the release of main granulocyte components: in vivo and in vitro studies. (1988) (0)
Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease? (2009) (0)
Blood Cooling Prevents Degranulation of Neutrophils During Hemodialysis (1989) (0)
Impaired hormonal stimulation in isolated hepatocytes of phosphorous depleted rats. (1984) (0)
INITIAL COMBINATION THERAPY WITH OLMESARTAN/HYDROCHLOROTHIAZIDE SHOWS SUPERIOR BLOOD PRESSURE CONTROL RATE IN MODERATE TO SEVERE HYPERTENSION: P3.324 (2004) (0)
Fresenius Polysulfone--membrane developments to meet clinical demands. (1994) (0)
Contents, Vol. 45, 1987 (2004) (0)
High molecular weight uremic toxins (1998) (0)
Foreword (2005) (0)
Effect of Immunosuppresion on the Release of Main Granulocyte Components: In Vivo and in Vitro Studies (1988) (0)
Leukocyte scintigraphy with 99mTc-exametazime-labeled leukocytes is not useful for follow-up of systemic vasculitis. (2002) (0)
Kidney independent serine synthesis in the rat. Effect of dietary serine and glycine restriction. (1985) (0)
Neutrophil Function in Uremia: Inhibition by Endogenous Plasma Inhibitor(s) (1991) (0)
Contents, Vol. 7, 1989 (1989) (0)
Subject Index, Vol. 7, 1989 (1989) (0)
The Role of Proteolytic Enzymes in the Treatment of Acute Hepatic Failure with Plasmapheresis (1983) (0)
Impaired cellular host defense and chronic inflammatory abnormalities in end-stage renal disease (2004) (0)
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)]. (1982) (0)
Serine and metallo proteinases in acute renal failure. (1987) (0)
Abstracts 143–295 (2000) (0)
Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis (2021) (0)
Treatment of acquired factor viii autoantibodies by immunoadsorption (2001) (0)
Subject Index, Vol. 11, 1991 (1991) (0)
Subject Index, Vol. 45, 1987 (1987) (0)
Gender-associated differences in dialysis patients (2013) (0)
[Invited comment on: Hans Eppinger, Karl Kloss: What should the practicing physician know about the current status of the nephritis topic? From: Wien med Wschr 1920;71:38-40; Wien med Wschr 1920;71:145-149; Wien med Wschr 1920;71:194-198]. (2000) (0)
LaudatioJoel D. Kopple (1998) (0)
Insulin improves the efficiency of intradialytic parenteral nutrition (IDPN) (2007) (0)
The European Survey on Anaemia Management (ESAM): Indicators of current practices of anaemia care in patients with end-stage renal disease (2001) (0)
[Goal blood pressure values from the nephrologic viewpoint]. (1999) (0)
Acknowledgement to Reviewers (2010) (0)
Editorial (2003) (0)
Cellular Aspects of Biocompatibility (1989) (0)
[Effects of diuretics after pretreatment with reserpine and 6-OH-dopamine (author's transl)]. (1976) (0)
Author and Subject Index (1998) (0)
Urinary excretion of proteolytic activity in catabolic states. (1988) (0)
Present status at the Vienna Transplantation Center after four thousand renal transplantations. (2007) (0)
Subject Index Vol. 25, 2002 (2003) (0)
Renal medicine and renal transplantation. (2000) (0)
[Diagnosis and therapy of renal anemia. Iron levels should be watched carefully: MMW Seminar on Anemia. 2]. (1999) (0)
Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis? (2014) (0)
Nifedipine inhibits granulocyte activation during cardiopulmonary bypass (1987) (0)
Effect of cyclosporin A, azathioprine, and prednisolone on carbohydrate metabolism of rat hepatocytes (1990) (0)
Contents, Vol. 35, 1983 (1983) (0)
Front & Back Matter (2012) (0)
Role of proteases in patients with acute renal failure and regular hemodialysis therapy. (1988) (0)
Management of anemia in patients with chronic kidney disease (2004) (0)
Practical Guide to Diagnosis and Differential Diagnosis of ARF in the ICU (1996) (0)
Title Pages / Contents (1999) (0)
Gilbert Thomas Thiel: Recipient of the Volhard Medal 2000 (2000) (0)
Section dedicated to: Carl William Gottschalk (1999) (0)
Glucose metabolism and blood pressure remain unchanged by addition of angiotensin receptor blocker in patients undergoing hemodialysis (2011) (0)
Acute uremia following dietary potassium depletion. II. Effect on tissue carbohydrate composition. (1987) (0)
[Reflections on the World Congress for Nephrology]. (2003) (0)
[Acute myoglobinuric kidney failure in McArdle's syndrome. The diagnostic significance of 31P nuclear magnetic resonance spectroscopy]. (1993) (0)
Buccal spray insulin in subjects with impaired glucose tolerance: Improvement in HbA1c is lost after 6 months washout therapy (2013) (0)
Lipids and the Kidney (Preliminary Pages) (1997) (0)
Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients. (2000) (0)
CKD 5D epidemiology and outcomes (2012) (0)
Contents Vol. 81, 1999 (1999) (0)
Subject Index, Vol. 5, 1987 (1987) (0)
[Tumor lysis syndrome: risk factors and treatment]. (2005) (0)
[Gangrene of the forefoot in disseminated lupus erythematosus with involvement of the large arteries of the extremity]. (1986) (0)
[Peritoneal dialysis - an alternative to hemodialysis in the center]. (2013) (0)
Catheter‐related infections in peritoneal dialysis patients: New aspects (1998) (0)
[Sequelae of hypertenson: kidney disease]. (2006) (0)
Abstracts 296–445 (2000) (0)
[Drug-induced kidney diseases. I. Analgesics and non-steroidal antirheumatic drugs]. (1986) (0)
[Drug-induced kidney injuries. II. Cytostatics and antibiotics]. (1987) (0)
Carbohydrate metabolism of salivary glands of acutely uremic rats. (1983) (0)
Mechanistic Target of Rapamycin Control Innate Immune Responses via Senses Environmental Stress To α p38 (2013) (0)
Prophylaxis and Conservative Management of Acute Renal Failure in the ICU (1996) (0)
Subject Index, Vol. 35, 1983 (1983) (0)
Effect of MTHFR 1298A3C andMTHFR 677C3T Genotypes on Total Homocysteine, Folate, and Vitamin B (2000) (0)
Subject Index, Vol. 13, 1993 (1993) (0)
[Prevention and conservative therapy of acute kidney failure]. (1993) (0)
[ACE inhibitors and the kidney]. (1996) (0)
Renal transplantation - basic research (2009) (0)
CONVERSION OF IMMUNOSUPPRESSION TO TACROLIMUS/MMF DOES NOT PREVENT DETERIORATION OF GRAFT FUNCTION IN C4D-POSITIVE CHRONIC ALLOGRAFT NEPHROPATHY (2004) (0)
Cellular aspects of nutrition (1996) (0)
TGF‐β1 impairs homocysteine metabolism in human renal cells: possible implications for transplantation (2003) (0)
5, 10-MTHFR (C677T) Gene Polymorphism and Total Homocysteine Levels in Renal Transplant Recipients (1998) (0)
Uremic toxicity : proceedings of the Fourth International Congress on Uremic Toxicity, Vienna, Austria, November 20-23, 1999 (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walter Hermann Hörl?

Walter Hermann Hörl is affiliated with the following schools: